diff --git a/annotated-projects/PXD008841/PXD008841.sdrf.tsv b/annotated-projects/PXD008841/PXD008841.sdrf.tsv
new file mode 100644
index 00000000..f1782480
--- /dev/null
+++ b/annotated-projects/PXD008841/PXD008841.sdrf.tsv
@@ -0,0 +1,3601 @@
+source name	characteristics[organism]	characteristics[organism part]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[cell type]	characteristics[biological replicate]	characteristics[pooled sample]	characteristics[disease]	assay name	technology type	comment[data file]	comment[technical replicate]	comment[fraction identifier]	comment[label]	comment[instrument]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[cleavage agent details]	comment[modification parameters]	comment[modification parameters].1	comment[modification parameters].2	comment[modification parameters].3	comment[modification parameters].4	comment[modification parameters].5	comment[file uri]	factor value[disease]
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr01.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr02.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr03.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr04.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr05.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr06.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr07.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr08.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr09.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr10.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr11.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr12.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr13.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr14.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr15.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr16.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr17.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr18.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr19.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr20.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr21.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr22.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr23.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr24.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr25.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr26.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr27.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr28.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr29.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr30.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr31.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr32.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr33.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr34.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr35.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr36.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr37.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr38.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr39.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr40.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr41.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr42.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr43.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr44.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr45.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr46.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr47.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr48.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr49.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr50.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr51.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr52.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr53.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr54.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr55.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr56.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr57.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr58.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr59.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr60.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr61.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr62.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr63.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr64.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr65.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr66.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr67.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr68.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr69.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr70.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr71.raw	breast cancer
+OSL.53E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	basal-like breast carcinoma
+OSL.567	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	luminal A breast carcinoma
+OSL.3FF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	basal-like breast carcinoma
+OSL.55F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	basal-like breast carcinoma
+OSL.46A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	basal-like breast carcinoma
+OSL.4B0	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	luminal A breast carcinoma
+OSL.4D6	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 1, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	basal-like breast carcinoma
+OSL.485	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	luminal A breast carcinoma
+OSL.41B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 1, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	luminal A breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 1, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool1_300ugIPG37-49_7of15ul_fr72.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 1	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr01.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 2	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr02.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 3	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr03.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 4	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr04.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 5	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr05.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 6	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr06.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 7	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr07.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 8	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr08.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 9	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr09.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 10	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr10.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 11	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr11.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 12	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr12.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 13	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr13.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 14	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr14.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 15	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr15.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 16	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr16.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 17	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr17.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 18	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr18.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 19	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr19.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 20	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr20.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 21	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr21.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 22	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr22.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 23	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr23.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 24	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr24.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 25	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr25.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 26	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr26.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 27	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr27.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 28	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr28.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 29	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr29.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 30	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr30.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 31	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr31.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 32	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr32.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 33	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr33.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 34	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr34.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 35	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr35.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 36	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr36.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 37	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr37.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 38	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr38.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 39	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr39.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 40	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr40.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 41	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr41.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 42	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr42.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 43	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr43.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 44	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr44.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 45	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr45.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 46	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr46.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 47	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr47.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 48	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr48.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 49	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr49.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 50	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr50.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 51	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr51.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 52	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr52.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 53	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr53.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 54	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr54.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 55	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr55.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 56	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr56.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 57	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr57.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 58	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr58.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 59	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr59.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 60	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr60.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 61	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr61.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 62	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr62.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 63	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr63.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 64	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr64.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 65	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr65.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 66	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr66.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 67	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr67.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 68	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr68.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 69	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr69.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 70	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr70.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 71	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr71.raw	breast cancer
+OSL.4AF	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	luminal A breast carcinoma
+OSL.46E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	luminal A breast carcinoma
+OSL.494	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	luminal A breast carcinoma
+OSL.457	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	luminal A breast carcinoma
+OSL.48B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal A breast carcinoma	pool 2, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	luminal A breast carcinoma
+OSL.4B4	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	basal-like breast carcinoma
+OSL.449	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	basal-like breast carcinoma
+OSL.44E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	basal-like breast carcinoma
+OSL.3EB	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	basal-like breast carcinoma	pool 2, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	basal-like breast carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 2, fraction 72	proteomic profiling by mass spectrometry	HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOS2U_20140410_TMTpool2_300ugIPG37-49_7of15ul_fr72.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr01.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr02.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr03.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr04.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr05.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr06.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr07.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr08.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr09.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr10.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr11.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr12.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr13.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr14.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr15.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr16.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr17.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr18.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr19.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr20.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr21.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr22.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr23.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr24.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr25.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr26.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr27.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr28.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr29.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr30.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr31.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr32.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr33.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr34.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr35.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr36.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr37.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr38.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr39.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr40.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr41.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr42.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr43.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr44.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr45.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr46.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr47.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr48.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr49.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr50.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr51.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr52.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr53.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr54.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr55.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr56.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr57.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr58.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr59.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr60.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr61.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr62.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr63.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr64.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr65.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr66.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr67.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr68.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr69.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr70.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr71.raw	breast cancer
+OSL.43C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	HER2 Positive Breast Carcinoma
+OSL.493	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	HER2 Positive Breast Carcinoma
+OSL.4D9	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 3, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	HER2 Positive Breast Carcinoma
+OSL.56F	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	luminal B breast carcinoma
+OSL.405	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	luminal B breast carcinoma
+OSL.49E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 3, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	luminal B breast carcinoma
+OSL.441	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.430	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.4FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 3, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 3, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150318_TMT_pool3_300ugIPG37-49_7of15ul_fr72.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr01.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr02.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr03.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr04.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr05.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr06.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr07.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr08.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr09.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr10.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr11.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr12.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr13.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr14.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr15.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr16.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr17.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr18.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr19.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr20.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr21.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr22.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr23.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr24.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr25.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr26.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr27.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr28.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr29.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr30.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr31.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr32.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr33.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr34.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr35.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr36.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr37.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr38.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr39.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr40.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr41.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr42.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr43.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr44.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr45.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr46.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr47.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr48.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr49.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr50.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr51.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr52.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr53.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr54.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr55.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr56.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr57.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr58.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr59.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr60.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr61.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr62.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr63.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr64.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr65.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr66.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr67.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr68.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr69.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr70.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr71.raw	breast cancer
+OSL.43A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	HER2 Positive Breast Carcinoma
+OSL.406	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	HER2 Positive Breast Carcinoma
+OSL.47C	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 4, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	HER2 Positive Breast Carcinoma
+OSL.524	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	luminal B breast carcinoma
+OSL.443	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	luminal B breast carcinoma
+OSL.458	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 4, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	luminal B breast carcinoma
+OSL.53D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.540	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.42E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 4, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 4, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150322_TMT_pool4_300ugIPG37-49_7of15ul_fr72.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 1	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	1	1	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr01.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 2	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	1	2	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr02.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 3	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	1	3	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr03.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 4	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	1	4	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr04.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 5	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	1	5	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr05.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 6	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	1	6	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr06.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 7	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	1	7	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr07.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 8	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	1	8	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr08.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 9	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	1	9	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr09.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 10	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	1	10	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr10.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 11	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	1	11	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr11.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 12	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	1	12	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr12.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 13	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	1	13	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr13.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 14	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	1	14	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr14.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 15	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	1	15	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr15.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 16	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	1	16	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr16.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 17	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	1	17	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr17.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 18	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	1	18	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr18.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 19	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	1	19	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr19.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 20	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	1	20	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr20.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 21	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	1	21	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr21.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 22	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	1	22	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr22.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 23	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	1	23	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr23.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 24	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	1	24	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr24.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 25	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	1	25	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr25.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 26	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	1	26	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr26.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 27	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	1	27	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr27.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 28	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	1	28	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr28.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 29	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	1	29	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr29.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 30	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	1	30	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr30.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 31	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	1	31	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr31.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 32	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	1	32	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr32.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 33	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	1	33	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr33.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 34	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	1	34	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr34.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 35	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	1	35	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr35.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 36	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	1	36	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr36.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 37	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	1	37	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr37.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 38	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	1	38	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr38.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 39	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	1	39	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr39.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 40	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	1	40	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr40.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 41	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	1	41	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr41.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 42	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	1	42	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr42.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 43	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	1	43	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr43.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 44	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	1	44	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr44.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 45	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	1	45	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr45.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 46	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	1	46	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr46.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 47	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	1	47	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr47.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 48	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	1	48	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr48.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 49	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	1	49	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr49.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 50	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	1	50	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr50.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 51	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	1	51	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr51.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 52	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	1	52	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr52.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 53	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	1	53	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr53.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 54	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	1	54	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr54.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 55	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	1	55	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr55.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 56	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	1	56	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr56.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 57	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	1	57	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr57.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 58	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	1	58	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr58.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 59	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	1	59	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr59.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 60	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	1	60	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr60.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 61	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	1	61	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr61.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 62	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	1	62	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr62.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 63	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	1	63	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr63.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 64	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	1	64	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr64.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 65	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	1	65	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr65.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 66	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	1	66	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr66.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 67	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	1	67	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr67.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 68	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	1	68	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr68.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 69	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	1	69	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr69.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 70	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	1	70	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr70.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 71	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	1	71	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr71.raw	breast cancer
+OSL.40A	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT126	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	HER2 Positive Breast Carcinoma
+OSL.40E	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT127N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	HER2 Positive Breast Carcinoma
+OSL.3FA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	HER2 Positive Breast Carcinoma	pool 5, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT127C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	HER2 Positive Breast Carcinoma
+OSL.521	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT128N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	luminal B breast carcinoma
+OSL.46D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT128C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	luminal B breast carcinoma
+OSL.54D	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	luminal B breast carcinoma	pool 5, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT129N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	luminal B breast carcinoma
+OSL.4BA	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT129C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.579	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT130N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	Normal Breast-Like Subtype of Breast Carcinoma
+OSL.57B	Homo Sapiens	breast	not available	not available	female	malignant cell	1	not pooled	Normal Breast-Like Subtype of Breast Carcinoma	pool 5, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT130C	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	Normal Breast-Like Subtype of Breast Carcinoma
+pool	Homo Sapiens	breast	not available	not available	female	malignant cell	1	SN=OSL.53E,OSL.567,OSL.3FF,OSL.55F,OSL.46A,OSL.4B0,OSL.4D6,OSL.485,OSL.41B,OSL.4AF,OSL.46E,OSL.494,OSL.457,OSL.48B,OSL.4B4,OSL.449,OSL.44E,OSL.3EB,OSL.43C,OSL.493,OSL.4D9,OSL.56F,OSL.405,OSL.49E,OSL.441,OSL.430,OSL.4FA,OSL.43A,OSL.406,OSL.47C,OSL.524,OSL.443,OSL.458,OSL.53D,OSL.540,OSL.42E,OSL.40A,OSL.40E,OSL.3FA,OSL.521,OSL.46D,OSL.54D,OSL.4BA,OSL.579,OSL.57B	breast cancer	pool 5, fraction 72	proteomic profiling by mass spectrometry	HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	1	72	TMT131N	Q Exactive	20.0 ppm	5.0 ppm	NT=Trypsin/P;CS=(?<=[KR])	NT=Oxidation;MT=Variable;PP=Anywhere;TA=M;MM=15.99490	NT=Acetyl;MT=Variable;PP=Protein N-term;MM=42.01060	NT=TMT6plex;MT=Variable;PP=Any N-term;MM=229.16293	NT=TMT6plex;MT=Variable;PP=Anywhere;TA=S;MM=229.16293	NT=Carbamidomethyl;MT=Fixed;PP=Anywhere;TA=C;MM=57.02146	NT=TMT6plex;MT=Fixed;PP=Anywhere;TA=K;MM=229.16293	https://storage.jpostdb.org/JPST000265/HJOSLO2U_QEHF_20150329_TMT_pool5_300ugIPG37-49_7of15ul_fr72.raw	breast cancer